Skip to main content

Table 5 Content uniformity for ELX (Orilissa® tablets) using the proposed method

From: Ultra-sensitive and selective fluorescence approach for estimation of elagolix in real human plasma and content uniformity using boron-doped carbon quantum dots

Dosage form No

% labeled claim

Orilissa® tablets (200 mg/tab)

1

99.11

2

100.45

3

98.99

4

99.11

5

100.22

6

98.88

7

100.11

8

99.60

9

99.93

10

100.02

Mean

99.64

SD

0.57

RSD

0.57

Acceptance value (AV)*

1.4

Max. allowed AV (L1)*

15

  1. *Acceptance value = 2.4 × SD
Back to article page

BMC Chemistry

ISSN: 2661-801X

Contact us